文献速递哮喘

性别对重症哮喘的影响:英国初级与专科诊疗的横断面回顾性分析

Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care.
PubMed 文献 · Thorax · 2024-04-15

该研究基于英国重症哮喘登记库(UKSAR)和Optimum Patient Care研究数据库(OPCRD),回顾性分析重症哮喘患者的性别差异。女性患者症状负担更重、肥胖比例更高,但FEV1%预计值更高、2型生物标志物(IgE、FeNO)更低,维持口服糖皮质激素使用更少。

要点

  • 女性重症哮喘患者症状评分更高,但FEV1%预计值优于男性。
  • 女性患者2型生物标志物IgE和FeNO水平显著低于男性。
  • 女性肥胖风险更高,但维持口服糖皮质激素使用更少。

核心结论

  • 女性重症哮喘患者症状更重且更易肥胖,尽管FEV1%预计值更高且2型生物标志物更低,两数据集差异一致且具临床重要性。

主要发现

  • 女性哮喘控制问卷-6评分更高(UKSAR调整OR 1.14,95%CI 1.09-1.18),皇家内科医师学会-3问题评分更高(OPCRD调整OR 1.29,95%CI 1.13-1.47)。
  • 女性FEV1%预计值更高(UKSAR 68.7% vs 64.8%,p<0.001),但呼气峰流速无显著差异。
  • 女性IgE(UKSAR 129 IU/mL vs 208 IU/mL,p<0.001)和FeNO(UKSAR 36ppb vs 46ppb,p<0.001)更低,血嗜酸性粒细胞和生物制剂使用无显著差异。

临床怎么用

  • 临床评估重症哮喘时应关注性别差异,女性患者可能症状重但2型炎症标志物较低,需综合评估。
  • 对女性重症哮喘患者应重视肥胖管理,并注意其口服糖皮质激素使用可能较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: After puberty, females are more likely to develop asthma and in a more severe form than males. The associations between asthma and sex are complex with multiple intrinsic and external factors. AIM: To evaluate the sex differences in the characteristics and treatment of patients with severe asthma (SA) in a real-world setting. METHODS: Demographic, clinical and treatment characteristics for patients with SA in the UK Severe Asthma Registry (UKSAR) and Optimum Patient Care Research Database (OPCRD) were retrospectively analysed by sex using univariable and multivariable logistic regression analyses adjusted for year, age and hospital/practice. RESULTS: 3679 (60.9% female) patients from UKSAR and 18 369 patients (67.9% female) from OPCRD with SA were included. Females were more likely to be symptomatic with increased Asthma Control Questionnaire-6 (UKSAR adjusted OR (aOR) 1.14, 95% CI 1.09 to 1.18) and Royal College of Physicians-3 Question scores (OPCRD aOR 1.29, 95% CI 1.13 to 1.47). However, they had a higher forced expiratory volume in 1 second per cent (FEV1%) predicted (UKSAR 68.7% vs 64.8%, p<0.001) with no significant difference in peak expiratory flow. Type 2 biomarkers IgE (UKSAR 129 IU/mL vs 208 IU/mL, p<0.001) and FeNO (UKSAR 36ppb vs 46ppb, p<0.001) were lower in females with no significant difference in blood eosinophils or biological therapy. Females were less likely to be on maintenance oral corticosteroids (UKSAR aOR 0.86, 95% CI 0.75 to 0.99) but more likely to be obese (UKSAR aOR 1.67, 95% CI 145 to 1.93; OPCRD SA aOR 1.46, 95% CI 1.34 to 1.58). CONCLUSIONS: Females had increased symptoms and were more likely to be obese despite higher FEV1% predicted and lower type 2 biomarkers with consistent and clinically important differences across both datasets.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Loewenthal L, Busby J, McDowell R, et al. Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care. Thorax. 2024. PMID: 38124220. doi:10.1136/thorax-2023-220512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。